News for Annovis Bio, Inc. (ANVS)

MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) — via IBN – Annovis Bio, Inc. (NYSE: ANVS)  (“Annovis” or the “Company”), a clinical-stage drug platform company deve…

**media[534970]**

MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company p…

**media[532257]**

Late-stage clinical drug platform company Annovis Bio, Inc. (ANVS), Monday announced the pricing of 5.25 million common stock and warrants to purchase an equal number of shares at a combined price of $4 per share, amounting to a total of $21 million.

**media[530590]**

**media[529417]**

MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) — via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company …

LOS ANGELES, Dec. 05, 2024 (GLOBE NEWSWIRE) -- via IBN -- InvestorBrandNetwork, a multifaceted communications organization engaged in connecting public compan

**media[484356]**

Annovis to Host Year-End Investor Webcast on December 11, 2024

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (

Annovis faces financial challenges and questionable efficacy in Alzheimer's and Parkinson's trials, risking poor stock performance. Learn more on ANVS stock here.

Oct. 17, 2024 ”“ The market is enthusiastic to Annovis Bio, Inc. (ANVS) and some say that they tackle Alzheimer's and Parkinson's in ways humanity has never ac

MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform...

The rising incidence of Alzheimer's and other tau-related disorders, driven by an aging global population, is significantly boosting the demand for...

NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) — NetworkNewsAudio –

MALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug...

The growing demand for corporate wellness is largely driven by factors such as increased screen time, higher workloads, rapid urbanization, poor diet,...